Location: Home
  • search
  • go
  • Relate News
  • 1/3/2025Eli Lilly China Launches Zepbound (tirzepatide) for Diabetes and Weigh...
  • 12/25/2024China NMPA Accepts NDA for ARS Pharma's Epinephrine Nasal Spray
  • 12/23/2024CORXEL Acquires ex-Greater China Rights to an Oral Small Molecule GLP...
  • 12/18/2024Gan & Lee Cleared for the U.S. IND for Bi-weekly GLP-1RA GZR18 Injecti...
  • 12/12/2024ARS Pharma Files for Approval of Neffy in China, Japan and Australia
  • 12/10/2024Eli Lilly Plans to Launch Weight Loss Drug in China Soon
  • 12/9/2024Domestic Pharma Cos Poised to Gain in Chinese GLP-1 Obesity Drug Marke...
  • 12/3/2024Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...
  • 11/27/2024CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
  • 11/18/2024Novo Nordisk Launches Weight Loss Drug Wegovy in China
  • 11/13/2024Shanghai Pharma Considers API Partnerships with Indian Drugmakers amid...
  • 11/12/2024Shanghai Pharma Eyes Stronger India Partnership for Global Growth
  • 11/6/2024Novo Nordisk Reports Strong Growth in China for 3Qs of 2024, Driven by...
  • 10/30/2024Eli Lilly's Weight-Loss Drug Mounjaro Set to Debut in Hong Kong
  • 10/25/2024China Succeeds in Reducing Premature Death from Chronic Diseases
  • 10/21/2024China Releases First National Guidelines for Obesity Diagnosis and Tre...
  • 10/21/2024China Sees Drop in Deaths from Chronic Diseases as Efforts Intensify A...
  • 10/17/2024Gan & Lee Achieves Primary Endpoints in Phase 2 Trials of Three Diabet...
  • 10/15/2024BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...
  • 10/15/2024Eli Lilly Invests $200M to Expand Chinese Manufacturing Facility for D...
  • 10/1/2024Kailera Secures $400M Series A Funding to Develop Obesity and Diabetes...
  • 9/9/2024NHC Issues the List of Pediatric Drugs Encouraged for R&D and Registra...
  • 8/27/2024BrightGene Announces Positive Phase II Results for Diabetes Drug BGM05...
  • 8/26/2024Recent Study Reveals Alarming Rise in Obesity-Related Cancers in China
  • 8/1/2024NMPA Accepts NDA for Innovent's T2D Drug Mazdutide
  • 7/22/2024Gan & Lee Unveils Promising Mid-Stage Data for Homegrown Obesity Drug
  • 7/19/2024Eli Lilly Wins Label Expansion for Tirzepatide in China
  • 7/19/2024Experts Predict Novo Victory in Grueling Chinese Patent Case (MedWatcj...
  • 7/18/2024India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...
  • 7/10/2024China Initiates New Awareness Campaign to Address Rising Obesity Rates
  • Page:2/42 Total number of articles:1256: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group